Latest News | Dr Reddy's Laboratories Launches Icosapent Ethyl Capsules in US
Get latest articles and stories on Latest News at LatestLY. Dr Reddy's Laboratories on Tuesday announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.
New Delhi, Jun 22 (PTI) Dr Reddy's Laboratories on Tuesday announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.
The company has launched Icosapent Ethyl Capsules in 1 gram strength after approval by the US Food and Drug Administration (USFDA), Dr Reddy's said in a regulatory filing.
Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120's count.
Dr Reddy's Icosapent Ethyl Capsules, 1 gram, is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE. SVK
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)